Epidermal necrolysis sequelae: A cohort study on prevalence and risk factors
Journal of the European Academy of Dermatology and Venereology · 2026
DOI: 10.1111/jdv.70547 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Journal of the European Academy of Dermatology and Venereology, 2026. Verfasst von Thanh Vy Nguyen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Dermatology Department, AP-HP, Henri Mondor Hospital, Créteil, France. Hauptthemen laut MEDLINE: Stevens-Johnson Syndrome. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Epidermal necrolysis (EN), including Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), is a rare but severe cutaneous reaction with a high risk of long‐term sequelae. However, data on their frequency, severity and socio‐professional impact remain limited.
Objectives
To describe the prevalence and severity of EN sequelae, and their associations with acute‐phase disease characteristics and long‐term functional outcomes.
Methods
This single‐centre retrospective study from 2015 to 2022 included all adult EN survivors with ≥ 3 months of follow‐up. Sequelae were classified according to anatomical systems and were graded by severity. Associations between sequelae and clinical variables were analysed with multivariable analyses and unsupervised clustering.
Results
We included 129 patients. One or more sequelae were observed in 93.8% of patients. Cutaneous (76%) and ocular (71.3%) sequelae were the most frequent. Severe ocular sequelae were associated with TEN diagnosis (OR: 2.07, 95% CI: 1.19–3.71), number of mucous membranes involved (OR: 1.56, 95% CI: 1.05–2.44) and length of stay (OR: 1.01 per day, 95% CI: 1.00–1.01), cutaneous sequelae were associated with TEN diagnosis (OR: 1.84, 95% CI: 1.15–2.97), while severe psychological sequelae (29.4%) only correlated with prior psychiatric history (OR: 2.33, 95% CI: 1.35–3.97). Clustering analysis identified three patient profiles: mild or no sequelae, severe cutaneous and pulmonary sequelae, and severe ocular, oral and genital sequelae. Almost half of active patients (43/88, 48.9%) did not return to work, mainly due to psychological sequelae ( p = 0.01).
Conclusions
EN survivors frequently experience multiple and severe sequelae, resulting in significant burden. Long‐term, multidisciplinary and personalized follow‐up is essential to improve patients' quality of life.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Dermatology Department, AP-HP, Henri Mondor Hospital, Créteil, France.
- Reference Center for Toxic Bullous Diseases and Severe Drug Reactions (TOXIBUL), Créteil, France.
- Université Paris-Est Créteil, EpiDermE, Créteil, France.
- Psychiatry Department, AP-HP, Henri Mondor Hospital, Créteil, France.
- Ophthalmology Department, Charles Nicolle University Hospital, Rouen, France.
- Ophthalmology Department, AP-HP, Henri Mondor Hospital, Créteil, France.
ORCID-Profile: Julie Gueudry, Emilie Sbidian, Saskia Ingen-Housz-Oro
Zitieren
APA
Nguyen, T. V., Bettuzzi, T., Zaghbib, K., Gueudry, J., Colin, A., Hareth, K. B., Terkmane, N., Sbidian, E., de Prost, N., & Ingen-Housz-Oro, S. (2026). Epidermal necrolysis sequelae: A cohort study on prevalence and risk factors. Journal of the European Academy of Dermatology and Venereology. https://doi.org/10.1111/jdv.70547
Vancouver
Nguyen TV, Bettuzzi T, Zaghbib K, Gueudry J, Colin A, Hareth KB, et al. Epidermal necrolysis sequelae: A cohort study on prevalence and risk factors. Journal of the European Academy of Dermatology and Venereology. 2026. doi:10.1111/jdv.70547
BibTeX
@article{Nguyen2026,
author = {Nguyen, Thanh Vy and Bettuzzi, Thomas and Zaghbib, Karim and Gueudry, Julie and Colin, Audrey and Hareth, Kmar Bel and Terkmane, Narimane and Sbidian, Emilie and de Prost, Nicolas and Ingen-Housz-Oro, Saskia},
title = {Epidermal necrolysis sequelae: A cohort study on prevalence and risk factors},
journal = {Journal of the European Academy of Dermatology and Venereology},
year = {2026},
doi = {10.1111/jdv.70547}
}
EUVIMED